✦ LIBER ✦

Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade

✍ Scribed by Dean J. Kereiakes; Scott D. Berkowitz; A.Michael Lincoff; James E. Tcheng; Kathy Wolski; Rob Achenbach; Richard Melsheimer; Keaven Anderson; Robert M. Califf; Eric J. Topol

Book ID: 117842122
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 110 KB
Volume: 140
Category: Article
ISSN: 1097-6744
DOI: 10.1067/mhj.2000.106615

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coronary perforation during percutaneous

Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management

✍ Eric J. Dippel; Dean J. Kereiakes; Daniel A. Tramuta; Thomas M. Broderick; Thoma 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 2 views

Safety of femoral closure devices after

Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade

✍ Fernando A. Cura; Samir R. Kapadia; Philippe L. L’Allier; Jakob P. Schneider; Ma 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Effects of platelet glycoprotein IIb/III

Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention

✍ George Dangas; Jonathan D. Marmur; Traci E. King; Joshua De Leon; Samin K. Sharm 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Rapid assessment of glycoprotein IIb/III

Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention

✍ Mina Madan; Scott D. Berkowitz; Douglas J. Christie; Lisa K. Jennings; Astrid C. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Direct Thrombin Inhibitors for Percutane

Direct Thrombin Inhibitors for Percutaneous Coronary Intervention in the Current Era of Platelet Glycoprotein IIb/IIIa Inhibition

✍ JOEL P. REGINELLI; DEREK CHEW 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Incidence and Predictors of Major Vascul

Incidence and Predictors of Major Vascular Complications after Percutaneous Coronary Intervention in the Glycoprotein IIb/IIIa Platelet Inhibitor Era

✍ RICHARD KONSTANCE; JAMES E. TCHENG; MARILYN B. WIGHTMAN; LARRY P. KELLY; ANNETTE 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB